Crysdale Industries Share Price

India's economic growth to exceed 6.5% in FY26, says Moody's Ratings

Delhivery, Tata: Trading strategies in stocks that hit 52-week lows

Gensol Engineering shares plunge 50% in 12 days; rating downgrades weigh

Global funds' asset under custody see second-worst plunge amid market rout

Zydus Lifesciences to buy 86% stake in Amplitude Surgical for $280 million

As per the attachment.

As per the attachment.

RELSON INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve 1. To consider and approve Unaudited Accounts and Financial Statements along with the Limited Review Report of the Company for the half year ended September 30 2022. 2. To consider any other matter with the permission of the Board.

<table border=1><tr bgcolor=#d6d6d6><th class=TTRow_left> No.of Investor complaints pending at the beginning of the quarter </th><th class=TTRow> No.of Investor complaints received during the quarter</th><th class=TTRow> No.of Investor complaints disposed of during the quarter </th><th class=TTRow> No.of Investor complaints unresolved at the end of the quarter </th></tr><tr><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td></tr></table><table border=1><tr><td > <span style=font-weight:bold>Name of the Signatory </span> </td><td> :- </td><td>Rajiv Gupta</td></tr><tr><td ><span style=font-weight:bold>Designation </span></td><td> :- </td><td>Any Other</td></tr></table>

Revised Intimation of resignation of Company Secretary & Compliance Officer of the Company pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015